Ermac, Danna L.
HRN: 24-59-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2024
AMPICILLIN 500MG (VIAL)
03/27/2024
04/03/2024
IV
300mg
Q6H
T/C CNS Infection
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes